AbCellera Biologics Inc. (ABCL)
NASDAQ$2.52
Market Cap
$750.93M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
114 of 924
Rank in Industry
79 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
ABCL Insider Trading Activity
ABCL Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,680,288 | 4 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Thermopylae Holdings Ltd. | 10 percent owner | 2 | $1.48M | 0 | $0 | $1.48M |
| Montalbano John S. | director | 2 | $198,068 | 0 | $0 | $198,068 |
About AbCellera Biologics Inc.
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is …
Insider Activity of AbCellera Biologics Inc.
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $1.68M and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $30.23M and sold $394.03M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thermopylae Holdings Ltd. (10 percent owner) — $1.48M. Montalbano John S. (director) — $198,068.
The last purchase of 343,631 shares for transaction amount of $742,243 was made by Thermopylae Holdings Ltd. (10 percent owner) on 2025‑03‑11.
List of Insider Buy and Sell Transactions, AbCellera Biologics Inc.
| 2025-03-11 | Thermopylae Holdings Ltd. | 10 percent owner | 343,631 0.1117% | $2.16 | $742,243 | +7.62% | ||
| 2025-03-10 | Montalbano John S. | director | 25,000 0.0088% | $2.30 | $57,500 | +7.95% | ||
| 2025-03-06 | Montalbano John S. | director | 60,000 0.0198% | $2.34 | $140,568 | -1.89% | ||
| 2024-08-29 | Thermopylae Holdings Ltd. | 10 percent owner | 283,516 0.0993% | $2.61 | $739,977 | +10.67% | ||
| 2023-11-08 | Montalbano John S. | director | 10,000 0.0037% | $4.46 | $44,600 | -7.89% | ||
| 2023-11-06 | Montalbano John S. | director | 20,000 0.0071% | $4.64 | $92,800 | -13.76% | ||
| 2023-09-22 | Hayden Michael R | director | 20,000 0.0066% | $4.91 | $98,200 | -14.30% | ||
| 2023-09-12 | Lecault Veronique | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -15.56% | ||
| 2023-08-08 | Hayden Michael R | director | 30,000 0.0104% | $5.90 | $177,000 | -23.77% | ||
| 2023-05-26 | Thermopylae Holdings Ltd. | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.25% | ||
| 2023-05-26 | Booth Andrew | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.25% | ||
| 2022-12-16 | Thermopylae Holdings Ltd. | director | 85,102 0.0295% | $10.10 | $859,249 | -33.50% | ||
| 2022-08-19 | Thermopylae Holdings Ltd. | 10 percent owner | 200,000 0.0702% | $11.46 | $2.29M | -20.94% | ||
| 2022-06-14 | Thermopylae Holdings Ltd. | 10 percent owner | 9,173 0.0029% | $8.05 | $73,842 | +16.48% | ||
| 2022-06-13 | Thermopylae Holdings Ltd. | 10 percent owner | 54,915 0.0189% | $8.03 | $441,066 | +25.00% | ||
| 2022-06-06 | Thermopylae Holdings Ltd. | 10 percent owner | 64,545 0.0222% | $7.50 | $483,965 | +33.64% | ||
| 2022-05-16 | Lecault Veronique | Chief Operating Officer | 200,000 0.057% | $6.34 | $1.27M | +31.24% | ||
| 2022-05-13 | Thermopylae Holdings Ltd. | 10 percent owner | 300,000 0.1057% | $7.26 | $2.18M | +41.77% | ||
| 2022-05-12 | Thermopylae Holdings Ltd. | 10 percent owner | 1.41M 0.4723% | $6.41 | $9.02M | +52.76% | ||
| 2022-05-12 | Booth Andrew | Chief Financial Officer | 85,000 0.0258% | $5.79 | $492,150 | +52.76% |
Total: 40
*Gray background shows transactions not older than one year
Insider Historical Profitability
<0.0001%
| Thermopylae Holdings Ltd. | 10 percent owner | 56143640 18.8409% | $141.48M | 11 | 1 | +6.35% |
| Montalbano John S. | director | 171000 0.0574% | $430,920.00 | 8 | 0 | <0.0001% |
| THIEL PETER | director | 10179880 3.4162% | $25.65M | 1 | 0 | <0.0001% |
| Lecault Veronique | Chief Operating Officer | 2040122 0.6846% | $5.14M | 4 | 1 | <0.0001% |
| Hayden Michael R | director | 1323397 0.4441% | $3.33M | 3 | 1 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$3,596,906 | 112 | 13.42% | $635.29M | |
$7,929,017 | 58 | 21.56% | $787.18M | |
$97,176 | 41 | 42.84% | $802.16M | |
$94,912,877 | 34 | -7.15% | $626.42M | |
$61,752,931 | 34 | 14.31% | $741.99M |
ABCL Institutional Investors: Active Positions
| Increased Positions | 72 | +46.75% | 18M | +15.91% |
| Decreased Positions | 59 | -38.31% | 7M | -6.55% |
| New Positions | 27 | New | 11M | New |
| Sold Out Positions | 16 | Sold Out | 775,526 | Sold Out |
| Total Postitions | 167 | +8.44% | 120M | +9.36% |
ABCL Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Baker Bros. Advisors Lp | $71,154.00 | 9.24% | 27.53M | 0 | 0% | 2024-12-31 |
| Baillie Gifford & Co | $31,631.00 | 4.11% | 12.24M | -658,238 | -5.11% | 2024-12-31 |
| Voya Investment Management Llc | $27,464.00 | 3.57% | 10.62M | 0 | 0% | 2024-12-31 |
| Capital World Investors | $20,508.00 | 2.66% | 7.93M | +8M | New | 2024-12-31 |
| Prosight Management, Lp | $19,000.00 | 2.47% | 7.35M | -2M | -19.05% | 2024-12-31 |
| Credit Suisse Ag/ | $11,755.00 | 1.53% | 4.55M | -30,935 | -0.68% | 2024-03-31 |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame | $11,633.00 | 1.51% | 4.5M | -90,103 | -1.96% | 2024-12-31 |
| Orbimed Advisors Llc | $10,807.00 | 1.4% | 4.18M | 0 | 0% | 2024-12-31 |
| Arrowmark Colorado Holdings Llc | $10,612.00 | 1.38% | 4.11M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $10,590.00 | 1.38% | 4.1M | +107,951 | +2.71% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.